C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022

Rhea-AI Summary

C4 Therapeutics (Nasdaq: CCCC) announced participation in the Bank of America Securities Precision Oncology Conference 2022. The event will occur on October 3, 2022, at 9:50 a.m. ET. C4T focuses on advancing targeted protein degradation science to develop innovative small-molecule medicines aimed at improving patient outcomes in oncology. The presentation will be available via live webcast on the company's website, with an archived replay accessible for 30 days post-event. C4T is leveraging its TORPEDO® platform to tackle challenging diseases.

WATERTOWN, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced that C4T management will participate in a fireside chat at the virtual Bank of America Securities Precision Oncology Conference 2022.

Presentation Details:
Event: Bank of America Securities Precision Oncology Conference 2022
Date/Time: Monday, October 3^rd, 2022 at 9:50 a.m. ET

A live webcast of the presentation will be available on the Investors section of the company’s website at www.c4therapeutics.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.

About C4 Therapeutics
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is leveraging its TORPEDO^® platform to efficiently design and optimize small-molecule medicines that harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. C4T is advancing multiple targeted oncology programs to the clinic and expanding its research platform to deliver the next wave of medicines for difficult-to-treat diseases. For more information, please visit www.c4therapeutics.com.

Investor Contact: 
Courtney Solberg 
Senior Manager, Investor Relations 
CSolberg@c4therapeutics.com

Media Contact: 
Loraine Spreen 
Director, Corporate Communications & Patient Advocacy
LSpreen@c4therapeutics.com

FAQ

When is C4 Therapeutics participating in the Precision Oncology Conference?

C4 Therapeutics will participate in the Bank of America Securities Precision Oncology Conference on October 3, 2022, at 9:50 a.m. ET.

How can I watch the C4 Therapeutics presentation at the conference?

You can watch the live webcast of C4 Therapeutics' presentation on their Investors section of the company's website.

What is the focus of C4 Therapeutics' research?

C4 Therapeutics focuses on targeted protein degradation science to develop small-molecule medicines for oncology.

Where can I find the archived presentation of C4 Therapeutics?

An archived replay of C4 Therapeutics' presentation from the conference will be available for approximately 30 days following the event.

What innovative platform is C4 Therapeutics using for drug development?

C4 Therapeutics is leveraging its TORPEDO® platform to design and optimize medicines that degrade disease-causing proteins.